Home » Authors » Larry Haimovitch

Articles by Larry Haimovitch

Innovative devices offer hope for improved stroke therapy

Oct. 1, 2002

By Larry Haimovitch

Innovative devices offer hope for improved stroke therapy

Sep. 1, 2002

By Larry Haimovitch

OmniSonics, Quinton outline therapeutic, financial progress

Sep. 1, 2002

By Larry Haimovitch

'Golden age' brings more improvements in cataract surgery

July 1, 2002

By Larry Haimovitch

Role of new heart failure devices debated by electrophysiologist

June 1, 2002

By Larry Haimovitch

CHF impact on large patient pool spells opportunity for device firms

Aug. 1, 2001

By Larry Haimovitch

Mixed trial results fuel controversy over ICD-pacing device

July 1, 2001

By Larry Haimovitch

Controversy aside, sizable market opportunity exists in TMR, PTMR

July 1, 2001

By Larry Haimovitch

Temperature management moves to forefront as stroke treatment

June 1, 2001

By Larry Haimovitch

Coronary 're-dos' still a major frustration to interventionalists

Dec. 1, 2000

By Larry Haimovitch

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Aug. 3, 2026.
Tuojie Biotech (Shanghai) synthesizes new SARM1 inhibitors
BioWorld Science
Tuojie Biotech (Shanghai) Co. Ltd. has prepared and tested NAD(+) hydrolase SARM1 (SAMD2; MyD88-5) inhibitors found to be potentially useful for the treatment of...
Death in Chinese gene-editing trial exposes ethical fault lines
BioWorld
The death of a 6-year-old girl after receiving an experimental brain-directed gene-editing therapy at the Xinhua Hospital in Shanghai has reopened debate over how...
Seed funding at Adjuvia to treat mitochondrial dysfunction
BioWorld Science
Adjuvia Therapeutics Inc. has closed a $8 million series seed financing round to advance its work developing therapeutics to treat mitochondrial dysfunction and...
Replimune’s RP-1 for melanoma wins over FDA adcom
BioWorld
Following two complete response letters in the past year, Replimune Group Inc.’s RP-1 (suvolimogene oderparepvec) for unresectable metastatic cutaneous melanoma...